Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ELAB - Elevai Labs Inc.


IEX Last Trade
2.42
0.030   1.240%

Share volume: 951
Last Updated: Thu 26 Dec 2024 08:29:34 PM CET
Toilet Preparation Manufacturing: 3.01%

PREVIOUS CLOSE
CHG
CHG%

$2.39
0.03
1.26%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
25%
Profitability 25%
Dept financing 17%
Liquidity 75%
Performance 15%
Company vs Stock growth
vs
Performance
5 Days
-9.96%
1 Month
18,700.00%
3 Months
2,540.45%
6 Months
305.17%
1 Year
35.06%
2 Year
-30.88%
Key data
Stock price
$2.42
P/E Ratio 
-1.25
DAY RANGE
$2.23 - $2.40
EPS 
-$0.40
52 WEEK RANGE
$0.01 - $3.89
52 WEEK CHANGE
$30.56
MARKET CAP 
5.379 M
YIELD 
N/A
SHARES OUTSTANDING 
20.192 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/14/2024
BETA 
1.45
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$3,593,075
AVERAGE 30 VOLUME 
$18,144,882
Company detail
CEO: Jordan R. Plews
Region: US
Website: elevailabs.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Toilet Preparation Manufacturing
Sector: Manufacturing

We are a physician-dispensed skincare company with a focus on modernizing aesthetic skincare. Elevai Labs, Inc. was incorporated in Delaware in June 2020 under the original name Reactive Medical Labs Inc. Upon completion of the stock transfer agreement, Reactive Medical Inc. became our wholly owned subsidiary. In September 2022, Reactive Medical Inc. changed its name to Elevai Research Inc. Our principal executive offices are located at 120 Newport Center Dr. #250, Newport Beach, CA 92660. As of the date of this prospectus, we are qualified to do business as a foreign corporation in the state of California. Our telephone number is 866-794-4940. Our website address is www.elevailabs.com.

Recent news